AML/MDS

Clinical trials for AML/MDS explained in plain language.

Never miss a new study

Get alerted when new AML/MDS trials appear

Sign up with your email to follow new studies for AML/MDS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet finished but already full! 1 Completed 1

Smart immune cells take aim at tough blood cancers

Disease control Ongoing

This early-stage trial tests a new therapy called SENTI-202, which uses specially designed immune cells (CAR NK cells) to find and attack cancer cells in people with certain blood cancers like acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). The cells are 'off-the…

Matched conditions: AML/MDS

Phase: PHASE1 • Sponsor: Senti Biosciences • Aim: Disease control

Last updated Jun 27, 2026 09:05 UTC

AML/MDS

Get alerted when new AML/MDS trials appear

Smart immune cells take aim at tough blood cancers